Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

Original Article

K. Papp, K. Gordon, D. Thaçi, A. Morita, M. Gooderham, P. Foley, I.G. Girgis, S. Kundu, and S. Banerjee

N Engl J Med 2018;379:1313-1321

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/03/2018
Course expires: 
10/04/2020

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, October 4, 2020 - 11:59pm.